$VERV is giving a GREAT IPO LONG opportunity today

IPO intraday trading strategy idea

Verve Therapeutics is genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course gene editing medicines.

The share price is rising and gonna continue this trend today.

The demand for shares of the company still looks higher than the supply.

These and other conditions can cause a rise in the share price today.

So I opened a long position from $31.50;
stop-loss — $27.14;
take-profit — $44.58/MOC price.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.